+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Biochips Market 2019-2027

  • ID: 4772786
  • Report
  • Region: Global
  • 128 pages
  • Triton Market Research
1 of 3

FEATURED COMPANIES

  • AGilent Technology Inc.
  • Biomerieux Sa
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina Inc.
  • Merck GmbH
  • MORE
Market Outlook

The global biochips market is projected to progress with 19.32% of CAGR over the forecast period of 2019-2027. The major driving factors in the global biochips market are the growth in personalized medicines, rising incidences & treatment of cancer, constant rise in worldwide healthcare spending and the increasing number of investments in biotechnology R&D. Moreover, the development in biochips technology, and the widening application areas are the key opportunities nudging growth of the market towards the projected period. However, challenges such as availability of substitute technologies, unclear regulatory guidelines and cost constraints are the factors restraining the biochips market growth.

Regional Outlook

Europe, Asia-Pacific, North America, and rest of the world are the four regional segments covered in the biochips market report. North America biochips market leads the global scene by capturing the largest share in the year 2018. The market is driven by the increasing number of investments in biotechnology R&D and the increasing market demand for personalized medicine. Over the forecasted period, the Asia Pacific region will dominate the global biochips market in terms of CAGR.

Competitive Outlook

Top players involved in the market include Fluidigm Corporation, Origene Technologies Inc., Thermo Fisher Scientific Inc., Gamida For Life Group., Biochain Institute Inc., Bio-Rad Laboratories Inc., Illumina Inc., Perkinelmer Inc., Cepheid Inc., Biomerieux Sa, Agilent Technology Inc., Merck Gmbh, Samsung Electronics Inc., Cybrdi Inc., and Imgenex.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AGilent Technology Inc.
  • Biomerieux Sa
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina Inc.
  • Merck GmbH
  • MORE
1. Biochips Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.3. Evolution & Transition of Biochips
2.4. Porter's Five Force Analysis
2.5. Market Attractiveness Matrix
2.6. Industry Components
2.7. Regulatory Framework
2.8. Vendor Scorecard
2.9. Key Impact Analysis
2.10. Market Opportunity Insights
2.11. Industry Player Positioning
2.12. Key Market Strategies
2.13. Market Drivers
2.13.1. Growth in Personalized Medicines
2.13.2. Rising Incidences & Treatment of Cancer
2.13.3. Constant Rise in Healthcare Spending Worldwide
2.13.4. Increasing Number of Investments in Biotechnology R&D
2.14. Market Restraints
2.14.1. Inequality in Healthcare Access
2.14.2. Inadequate Technical Awareness Related to Biochips
2.14.3. Complexity of Biological Systems
2.15. Market Opportunities
2.15.1. Developments in Biochips Technology
2.15.2. Asia Pacific to Offer Lucrative Growth Opportunities
2.15.3. Widening Application Areas of Biochips
2.16. Market Challenges
2.16.1. Availability of Substitute Technologies
2.16.2. Unclear Regulatory Guidelines
2.16.3. Cost Constraints

3. Biochips Industry Outlook - By Type
3.1. Dna Chips
3.1.1. Agricultural Biotechnology
3.1.2. Cancer Diagnostics & Treatment
3.1.3. Drug Discovery
3.1.4. Gene Expression
3.1.5. Genomics
3.1.6. Single Nucleotide Polymorphism (Snp) Genotyping
3.1.7. Other Dna Chips
3.2. Lab On a Chip
3.2.1. Clinical Diagnostics
3.2.2. Drug Discovery
3.2.3. Genomics
3.2.4. Point of Care & in Vitro Diagnosis
3.2.5. Proteomics
3.2.6. Other Lab On a Chip
3.3. Protein Chips
3.3.1. Diagnostics
3.3.2. Drug Discovery
3.3.3. Expression Profiling
3.3.4. High Throughput Screening
3.3.5. Proteomics
3.3.6. Other Protein Chips
3.4. Other Chips
3.4.1. Cell Arrays
3.4.2. Tissue Arrays

4. Biochips Industry Outlook - By Substrate Material
4.1. Glass
4.2. Polymers
4.3. Silicon
4.4. Other Substrate Materials

5. Biochips Industry Outlook - By End User
5.1. Biotechnology and Pharmaceutical Companies
5.2. Hospitals and Diagnostics Centers
5.3. Academic and Research Institute

6. Biochips Industry - Regional Outlook
6.1. North America
6.1.1. Market By Type
6.1.2. Market By Substrate Material
6.1.3. Market By End User
6.1.4. Country Analysis
6.1.4.1. United States
6.1.4.2. Canada
6.2. Europe
6.2.1. Market By Type
6.2.2. Market By Substrate Material
6.2.3. Market By End User
6.2.4. Country Analysis
6.2.4.1. United Kingdom
6.2.4.2. Germany
6.2.4.3. France
6.2.4.4. Italy
6.2.4.5. Spain
6.2.4.6. Russia
6.2.4.7. Rest of Europe
6.3. Asia Pacific
6.3.1. Market By Type
6.3.2. Market By Substrate Material
6.3.3. Market By End User
6.3.4. Country Analysis
6.3.4.1. China
6.3.4.2. Japan
6.3.4.3. India
6.3.4.4. South Korea
6.3.4.5. Asean Countries
6.3.4.6. Australia and New Zealand
6.3.4.7. Rest of Asia Pacific
6.4. Latin America
6.4.1. Market By Type
6.4.2. Market By Substrate Material
6.4.3. Market By End User
6.4.4. Country Analysis
6.4.4.1. Brazil
6.4.4.2. Mexico
6.4.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Market By Type
6.5.2. Market By Substrate Material
6.5.3. Market By End User
6.5.4. Country Analysis
6.5.4.1. United Arab Emirates
6.5.4.2. Turkey
6.5.4.3. Saudi Arabia
6.5.4.4. South Africa
6.5.4.5. Rest of Middle East & Africa

7. Competitive Landscape
7.1. Agilent Technology Inc.
7.2. Biochain Institute Inc.
7.3. Biomerieux Sa
7.4. Bio-Rad Laboratories Inc.
7.5. Cepheid Inc.
7.6. Cybrdi Inc.
7.7. Fluidigm Corporation
7.8. Gamida For Life Group
7.9. Illumina Inc.
7.10. Imgenex
7.11. Merck Gmbh
7.12. Origene Technologies Inc.
7.13. Perkinelmer Inc.
7.14. Samsung Electronics Inc.
7.15. Thermo Fisher Scientific Inc.

8. Methodology & Scope
8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology

List of Tables
Table 1. Market Attractiveness Matrix For Biochips Market
Table 2. Vendor Scorecard of Biochips Market
Table 3. Regulatory Framework of Biochips Market
Table 4. Key Strategic Developments in Biochips Market
Table 5. Estimated Number of New Cancer Cases & Estimated Deaths Due to Cancer in United States in 2017
Table 6. Notable Investments Made in Biotechnology Industry in 2017
Table 7. Estimated R&D Expenditure in Medical & Healthcare Industry of United States, 2013-2015 (In $ Millions)
Table 8. Estimated R&D Spending in Biotechnology, Pharmaceutical, & Medical Industry of United States, 2013-2015 (In $ Millions)
Table 9. Global Biochips Market, By Type, 2019-2027 (In $ Million)
Table 10. Global Biochips Market, By Substrate Material, 2019-2027 (In $ Million)
Table 11. Global Biochips Market, By End User, 2019-2027 (In $ Million)
Table 12. Global Biochips Market, Regional Outlook, 2019-2027 (In $ Million)
Table 13. North America Biochips Market, Country Outlook, 2019-2027 (In $ Million)
Table 14. North America Biochips Market, By Type, 2019-2027 (In $ Million)
Table 15. North America Biochips Market, By Substrate Material, 2019-2027 (In $ Million)
Table 16. North America Biochips Market, By End User, 2019-2027 (In $ Million)
Table 17. Europe Biochips Market, Country Outlook, 2019-2027 (In $ Million)
Table 18. Europe Biochips Market, By Type, 2019-2027 (In $ Million)
Table 19. Europe Biochips Market, By Substrate Material, 2019-2027 (In $ Million)
Table 20. Europe Biochips Market, By End User, 2019-2027 (In $ Million)
Table 21. Asia Pacific Biochips Market, Country Outlook, 2019-2027 (In $ Million)
Table 22. Asia Pacific Biochips Market, By Type, 2019-2027 (In $ Million)
Table 23. Asia Pacific Biochips Market, By Substrate Material, 2019-2027 (In $ Million)
Table 24. Asia Pacific Biochips Market, By End User, 2019-2027 (In $ Million)
Table 25. Latin America Biochips Market, Country Outlook, 2019-2027 (In $ Million)
Table 26. Latin America Biochips Market, By Type, 2019-2027 (In $ Million)
Table 27. Latin America Biochips Market, By Substrate Material, 2019-2027 (In $ Million)
Table 28. Latin America Biochips Market, By End User, 2019-2027 (In $ Million)
Table 29. Middle East & Africa Biochips Market, Country Outlook, 2019-2027 (In $ Million)
Table 30. Middle East & Africa Biochips Market, By Type, 2019-2027 (In $ Million)
Table 31. Middle East & Africa Biochips Market, By Substrate Material, 2019-2027 (In $ Million)
Table 32. Middle East & Africa Biochips Market, By End User, 2019-2027 (In $ Million)

List of Figures
Figure 1. Global Biochips Market, 2019-2027 (In $ Million)
Figure 2. Porter's Five Force Analysis of Biochips Market
Figure 3. Key Impact Analysis
Figure 4. Timeline of Biochips
Figure 5. Market Opportunity Insights, By Region, 2018
Figure 6. Market Opportunity Insights, By Type, 2018
Figure 7. Market Opportunity Insights, By End User, 2018
Figure 8. Industry Components of Biochips Market
Figure 9. Key Player Positioning in 2018 (%)
Figure 10. Worldwide Healthcare Spending, By Regions, 2014-2015 (% of Gdp)
Figure 11. United States Healthcare Spending, 2015-2025 (% of Gdp)
Figure 12. Comparison of Healthcare Spending Per Capita and Out of the Pocket Health Expenditure
Figure 13. Global Biochips Market, By Dna Chips, 2019-2027 (In $ Million)
Figure 14. Global Dna Chips Market, By Agricultural Biotechnology, 2019-2027 (In $ Million)
Figure 15. Global Dna Chips Market, By Cancer Diagnostics & Treatment, 2019-2027 (In $ Million)
Figure 16. Global Dna Chips Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 17. Global Dna Chips Market, By Gene Expression, 2019-2027 (In $ Million)
Figure 18. Global Dna Chips Market, By Genomics, 2019-2027 (In $ Million)
Figure 19. Global Dna Chips Market, By Single Nucleotide Polymorphism (Snp) Genotyping, 2019-2027 (In $ Million)
Figure 20. Global Dna Chips Market, By Other Chips, 2019-2027 (In $ Million)
Figure 21. Global Biochips Market, By Lab On a Chip, 2019-2027 (In $ Million)
Figure 22. Global Lab On a Chip Market, By Clinical Diagnostics, 2019-2027 (In $ Million)
Figure 23. Global Lab On a Chip Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 24. Global Lab On a Chip Market, By Genomics, 2019-2027 (In $ Million)
Figure 25. Global Lab On a Chip Market, By Point of Care (Poc) & in Vitro Diagnosis (Ivs), 2019-2027 (In $ Million)
Figure 26. Global Lab On a Chip Market, By Proteomics, 2019-2027 (In $ Million)
Figure 27. Global Lab On a Chip Market, By Other Lab On a Chip, 2019-2027 (In $ Million)
Figure 28. Global Biochips Market, By Protein Chips, 2019-2027 (In $ Million)
Figure 29. Global Protein Chips Market, By Diagnostics, 2019-2027 (In $ Million)
Figure 30. Global Protein Chips Market, By Drug Discovery, 2019-2027 (In $ Million)
Figure 31. Global Protein Chips Market, By Expression Profiling, 2019-2027 (In $ Million)
Figure 32. Global Protein Chips Market, By High Throughput Screening, 2019-2027 (In $ Million)
Figure 33. Global Protein Chips Market, By Proteomics, 2019-2027 (In $ Million)
Figure 34. Global Protein Chips Market, By Other Protein Chips, 2019-2027 (In $ Million)
Figure 35. Global Biochips Market, By Other Chips, 2019-2027 (In $ Million)
Figure 36. Global Other Biochips Market, By Cell Arrays, 2019-2027 (In $ Million)
Figure 37. Global Other Biochips Market, By Tissue Arrays, 2019-2027 (In $ Million)
Figure 38. Global Biochips Market, By Glass, 2019-2027 (In $ Millions)
Figure 39. Global Biochips Market, By Polymers, 2019-2027 (In $ Millions)
Figure 40. Global Biochips Market, By Silicon, 2019-2027 (In $ Millions)
Figure 41. Global Biochips Market, By Other Substrate Materials, 2019-2027 (In $ Millions)
Figure 42. Global Biochips Market, By Biotechnology and Pharmaceutical Companies, 2019-2027 (In $ Millions)
Figure 43. Global Biochips Market, By Hospitals and Diagnostics Centers, 2019-2027 (In $ Millions)
Figure 44. Global Biochips Market, By Academic and Research Institute, 2019-2027 (In $ Millions)
Figure 45. Global Biochips Market, Regional Outlook, 2018 & 2027 (In %)
Figure 46. United States Biochips Market, 2019-2027 (In $ Million)
Figure 47. Canada Biochips Market, 2019-2027 (In $ Million)
Figure 48. United Kingdom Biochips Market, 2019-2027 (In $ Million)
Figure 49. Germany Biochips Market, 2019-2027 (In $ Million)
Figure 50. France Biochips Market, 2019-2027 (In $ Million)
Figure 51. Italy Biochips Market, 2019-2027 (In $ Million)
Figure 52. Spain Biochips Market, 2019-2027 (In $ Million)
Figure 53. Russia Biochips Market, 2019-2027 (In $ Million)
Figure 54. Rest of Europe Biochips Market, 2019-2027 (In $ Million)
Figure 55. China Biochips Market, 2019-2027 (In $ Million)
Figure 56. Japan Biochips Market, 2019-2027 (In $ Million)
Figure 57. India Biochips Market, 2019-2027 (In $ Million)
Figure 58. South Korea Biochips Market, 2019-2027 (In $ Million)
Figure 59. Asean Countries Biochips Market, 2019-2027 (In $ Million)
Figure 60. Australia & New Zealand Biochips Market, 2019-2027 (In $ Million)
Figure 61. Rest of Asia-Pacific Biochips Market, 2019-2027 (In $ Million)
Figure 62. Brazil Biochips Market, 2019-2027 (In $ Million)
Figure 63. Mexico Biochips Market, 2019-2027 (In $ Million)
Figure 64. Rest of Latin America Biochips Market, 2019-2027 (In $ Million)
Figure 65. United Arab Emirates Biochips Market, 2019-2027 (In $ Million)
Figure 66. Saudi Arabia Biochips Market, 2019-2027 (In $ Million)
Figure 67. Turkey Biochips Market, 2019-2027 (In $ Million)
Figure 68. South Africa Biochips Market, 2019-2027 (In $ Million)
Figure 69. Rest of Middle East & Africa Biochips Market, 2019-2027 (In $ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AGilent Technology Inc.
  • Biochain Institute Inc.
  • Biomerieux Sa
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Cybrdi Inc.
  • Fluidigm Corporation
  • Gamida For Life Group
  • Illumina Inc.
  • Imgenex
  • Merck GmbH
  • Origene Technologies Inc.
  • Perkinelmer Inc.
  • Samsung Electronics Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll